Journalartikel

Clinical and Genetic Aspects of Juvenile Onset Pompe Disease


AutorenlisteHolzwarth, Johanna; Minopoli, Nadja; Pfrimmer, Charlotte; Smitka, Martin; Borrel, Sabine; Kirschner, Janbernd; Muschol, Nicole; Hartmann, Hans; Hennermann, Julia B.; Neubauer, Bernd A.; Hobbiebrunken, Elke; Husain, Ralf; Hahn, Andreas

Jahr der Veröffentlichung2022

Seiten39-45

ZeitschriftNeuropediatrics

Bandnummer53

Heftnummer01

ISSN0174-304X

eISSN1439-1899

Open Access StatusGreen

DOI Linkhttps://doi.org/10.1055/s-0041-1735250

VerlagThieme Publishing / Georg Thieme Verlag


Abstract
Little is known about clinical symptomatology and genetics of juvenile onset Pompe disease (JOPD). The aims of this study were to analyze how these children are diagnosed, what clinical problems they have, and how phenotype is related to genotype. To accomplish this, we analyzed retrospectively data of 34 patients diagnosed after their first and before completion of their 18th birthday. Median age at diagnosis was 3.9 (range 1.1-17) years. Eight patients (23.5%) developed initial symptoms in the first year, 12 (35%) between 1 and 7 years, and 6 (18%) thereafter. Eight (23.5%) had no clinical symptoms at the time of diagnosis. Indications for diagnostics were a positive family history in three (9%), hyperCKemia in eight (23.5%), motor developmental delay in three (9%), and muscle weakness and/or pain in 17 (50%). Rare clinical signs were failure to thrive, recurrent diarrhea, and suspected hepatopathy with glycogen storage. Thirty-two different mutations were identified. Twenty-seven patients (79.5%) carried the milder c.32-13T>G mutation, known to be associated with a broad range of phenotypes. Three out of eight patients manifesting within the first year of life showed generalized muscle weakness, hypertrophic cardiomyopathy, and had to be ventilated during the course of disease, thereby demonstrating clinical overlap with infantile onset Pompe disease. These findings demonstrate that the phenotype of JOPD is broad and that the differential is not only restricted to neuromuscular disorders. Genotypic analysis was useful to delineate subjects with early onset JOPD from those with IOPD, but overall genotype-phenotype correlation was poor.



Zitierstile

Harvard-ZitierstilHolzwarth, J., Minopoli, N., Pfrimmer, C., Smitka, M., Borrel, S., Kirschner, J., et al. (2022) Clinical and Genetic Aspects of Juvenile Onset Pompe Disease, Neuropediatrics, 53(01), pp. 39-45. https://doi.org/10.1055/s-0041-1735250

APA-ZitierstilHolzwarth, J., Minopoli, N., Pfrimmer, C., Smitka, M., Borrel, S., Kirschner, J., Muschol, N., Hartmann, H., Hennermann, J., Neubauer, B., Hobbiebrunken, E., Husain, R., & Hahn, A. (2022). Clinical and Genetic Aspects of Juvenile Onset Pompe Disease. Neuropediatrics. 53(01), 39-45. https://doi.org/10.1055/s-0041-1735250



Schlagwörter


ALGLUCOSIDASE ALPHAenzyme replacement therapyGLUCOSIDASEHYPERCKEMIAPompe disease


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:33